Showing results 32 to 51 of 174
< previous
next >
| Issue Date | Title | Author(s) |
| 2012 | Cumulative clinical experience from a decade of use: imatinib as first-line treatment of chronic myeloid leukemia | Baran, Yusuf ; Saydam, Güray |
| 2014 | Cytotoxic and apoptotic effects of fisetin, hesperetin and vitexinon acute promyelocytic leukemia cells | Adan Gökbulut, Aysun ; Baran, Yusuf |
| 2014 | Cytotoxic and cytostatic effects of ponatinib on imatinib-sensitive and-resistant chronic myeloid leukemia cells | Yandım, Melis Kartal; Baran, Yusuf |
| 2013 | Cytotoxic effects of apigenin on multiple myeloma cells | Baran, Yusuf ; Yılmaz, S. ; Cincin, Zeynep; Kozanoğlu, İlknur; Çakmakoğlu, Bedia; Özdoğu, Hakan |
| 2010 | Cytotoxic effects of resveratrol on imatinib sensitive and resistant K562 chronic myeloid leukemia cells | Can, Geylani; Baran, Yusuf |
| 2011 | Deciphering 5-fluorouracil mediated molecular mechanisms required for cell death | Can, Geylani |
| 2013 | Determination of cytotoxic and apoptotic effects of caffeic acid phenethyl ester and gossypol in combination with fludarabine at a molecular level in acute lymphoblastic leukemia cells | Baran, Yusuf ; İskender, G.; Pişkin, Özden; Özcan, Mehmet Ali |
| Jul-2021 | Determination of therapeutic effects of multifunctional antibody and peptide micelle-based nanocarriers on breast cancer cells | Abdulhadi, Nusaibah Abdulsalam Abdulhad |
| 2021 | Determination of therapeutic effects of multifunctional micelle-based nanocarriers on breast cancer cells | Ulu, Gizem Tuğçe ; Bayram, Nazende Nur; Abdulhadi, N.; Gurdap, S.; Isoglu, A.; Isoglu, S. D.; Baran, Yusuf |
| Jul-2019 | Determination of therapeutic effects of multifunctional micelle-based nanocarriers on breast cancer cells | Ulu, Gizem Tuğçe |
| Dec-2019 | Determination of therapeutic potential of apigenin on acute lymphoblastic leukemia cells | Uzuner, Erez |
| Nov-2019 | Determination of therapeutic potential of luteolin for acute lymphoblastic leukemia cells | Gürler, Sevim Beyza |
| 2020 | Determination of therapeutic potential of luteolin for Philadelphia chromosome positive acute lymphoblastic leukaemia cells | Gürler, Sevim Beyza; Baran, Yusuf ; Kiraz, Yağmur |
| 2013 | Diagnostic and therapeutic potentials of expression levels of bioactive sphingolipid genes in newly diagnosed and drug-resistant chronic myeloid leukemia patients | Baran, Yusuf ; Yandım, Melis; Kozanoğlu, İlknur; Özdoğu, Hakan; Pişkin, Özden; Özcan, Mehmet Ali |
| 2015 | Discovering alternative targets in chronic myeloid leukemia (CML): determination of expression levels of bioactive sphingolipid genes in newly diagnosed and drug-resistant CML patients | Kartal Yandım, Melis; Kozanoğlu, İlknur; Özdoğu, Hakan; Pişkin, Özden; Özcan, Mehmet Ali; Baran, Yusuf |
| Jun-2009 | Docetaxel enhances the cytotoxic effects of imatinib on Philadelphia positive human chronic myeloid leukemia cells | Güçlüler, Gözde; Baran, Yusuf |
| Feb-2009 | Docetaxel/zoledronic acid combination triggers apoptosis synergistically through downregulating antiapoptotic Bcl-2 protein level in hormone-refractory prostate cancer cells | Karabulut, B.; Erten, C.; Gül, M. K.; Cengiz, E.; Karaca, B.; Küçükzeybek, Y.; Görümlü, G.; Atmaca, H.; Uzunoğlu, S.; Şanlı, U. A.; Baran, Yusuf ; Uslu, R. |
| Jul-2011 | Effect of cobalt-60 (? radiation) on multidrug-resistant multiple myeloma cell lines | Mutlu, Pelin; Baran, Yusuf ; Ural, Ali Ugur; Avcu, Ferit; Dirican, Bahar; Beyzadeoglu, Murat; Gündüz, Ufuk |
| Sep-2017 | Effect of molecular architecture on cell interactions and stealth properties of PEG | Özer, İmran; Tomak, Aysel ; Zareie, Hadi M.; Baran, Yusuf ; Bulmuş, Volga |
| 2013 | Effect of nilotinib on the function of carotid artery endothelial cells | Katgı, Abdullah; Gökbulut, Aysun ; Sevindik, Ömer; Yüksel, Faize; Solmaz, Şerife; Özsan, Güner; Baran, Yusuf ; Pişkin, Özden |
